1. Compare the REDUCE-IT and STRENGTH trials.
2. Discuss the role of Lp(a) and CV disease.
3. Understand the causal role of inflammation in ASCVD and potential therapies.
Friday, April 9, 2021 - 12:00pm to 1:00pm
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Michael Davidson, MD